Back

Fundamentals III: Targeted Therapy Options in HR-Positive/ HER2-Negative Breast Cancer

In this certified on-demand micro-webcast, expand your knowledge on the array of targeted therapy options for patients with HR-positive/HER2-negative breast cancer and hear expert advice for combating treatment-related toxicities to ensure the optimal care for your patients.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.75 creditsAAPA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.75 credits
  • Commercial Support
  • Released
    May 6, 2026
  • Last day to claim credit
    Nov 6, 2026 4 weeks left